Meglumine antimonate
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101604This classification denotes an antihelminthic agent with the molecular formula C7H18NO8Sb, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75G4TW236W, chemically known as hydroxy(dioxo)-?5-stibane;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol but generally known as meglumine antimonate, which bears US NIH Compound Identifier 64953. European Medicines Agency schedules Meglumine Antimonate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12915MIG. World Health Organization schedules meglumine antimonate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule meglumine antimonate under HS 29221980 and SITC 51461. SMILES: CNCC(C(C(C(CO)O)O)O)O.O[Sb](=O)=O.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.